Testing the new Covaxin on patients taken full-swing in 6 cities in India!
Posted on: 25/Jul/2020 12:16:53 PM
Efforts on testing the new Covaxin for the coronavirus infection treatment on human beings have been intensified in 6 cities in India.
Covaxin, the new vaccine for trial for the treatment of the raging coronavirus pandemic has been created by the joint efforts of the Indian Council for Medical Research (ICMR), National Virology Institute, and Bharath Biotech.
Permission has been obtained from the Indian Medical regulation Council to test this vaccine on human patients.
Subsequently, activities have commenced for testing this Covaxin in 12 hospitals located in 12 cities throughout the country including Nagpur, Bhuvaneshwar, Kanpur, Goa, and Visakhapatnam. More than 500 volunteers have come forward registering to be tested with this vaccine.
With the trial already having been undertaken in Tamil Nadu SRM Medical College and in the cities Rohtak, Hyderabad, Patna, and Belgaum, trials have commenced in Delhi as well from yesterday (Saturday, 24th July).
Once the vaccine is received in the above test-locations, trials will commence. A hospital in Andhra has also been waiting for permission for trial on human patients.
Meanwhile, a 30-years old patient was administered with the new vaccine in Delhi yesterday (Friday, 24th July). After close monitoring of the patient after the administration of Covaxin, the doctors informed that there has been no harm. This patient was allowed to return home asking the patient to return after 2 days.
Apart from Bharath Biotech and Zydus Cadillac, the vaccine invented by Oxford University will also be tested in India.
Meanwhile, the price of the tablets ‘Favipiravir’, given for the coronavirus treatment, has come down by 40% in the last 1 month. As the Indian Medical Quality Regulation Council has given clearance for some more companies to manufacture this medicine, it is expected that the price will come down even further.
